Track topics on Twitter Track topics that are important to you
MONDAY, April 16, 2018 -- Drugs designed to trigger a patient's immune system may help boost survival for those battling lung cancer, two new studies found. The first study found that when the immunotherapy drug Keytruda (pembrolizumab) was...
Original Article: New Immunotherapy Drugs May Be Big Advance in Lung Cancer CareNEXT ARTICLE
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...